1. Yuan, H, Zhang, J, Li, F, et al. (2019) Retracted: sinomenine exerts antitumour effect in gastric cancer cells via enhancement of miR‐204 expression. Basic & Clinical Pharmacology & Toxicology 125(5): 450–459.
Google Scholar | Crossref | Medline2. Kurokawa, Y, Yang, H-K, Cho, H, et al. (2017) Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach. British Journal of Cancer 117(1): 25–32.
Google Scholar | Crossref | Medline3. Tsai, CL, Chiu, YM, Ho, TY, et al. (2018) Gallic acid induces apoptosis in human gastric adenocarcinoma cells. Anticancer research 38(4): 2057–2067.
Google Scholar | Medline4. Niccolai, E, Taddei, A, Prisco, D, et al. (2015) Gastric cancer and the epoch of immunotherapy approaches. World Journal of Gastroenterology 21(19): 5778–5793.
Google Scholar | Crossref | Medline5. Wagner, AD, Grothe, W, Haerting, J, et al. (2006) Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. Journal of Clinical Oncology 24(18): 2903–2909.
Google Scholar | Crossref | Medline6. Gao, L, Hao, J, Niu, Y-Y, et al. (2016) Network pharmacology dissection of multiscale mechanisms of herbal medicines in stage IV gastric adenocarcinoma treatment. Medicine 95(35): e4389.
Google Scholar | Crossref | Medline7. Qi, F, Li, A, Inagaki, Y, et al. (2010) Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Bioscience trends 4(6): 297–307.
Google Scholar | Medline | ISI8. Liao, Y-H, Li, C-I, Lin, C-C, et al. (2017) Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients. Journal of Cancer Research and Clinical Oncology 143(12): 2425–2435.
Google Scholar | Crossref | Medline9. Hung, K-F, Hsu, C-P, Chiang, J-H, et al. (2017) Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: a nationwide retrospective matched-cohort study. Journal of Ethnopharmacology 199: 168–174.
Google Scholar | Crossref | Medline10. Qi, F, Zhao, L, Zhou, A, et al. (2015) The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. BioScience Trends 9(1): 16–34.
Google Scholar | Crossref | Medline | ISI11. Schütz, K, Carle, R, Schieber, A (2006) Taraxacum--a review on its phytochemical and pharmacological profile. J Ethnopharmacol 107(3): 313–323.
Google Scholar | Crossref | Medline12. Tan, B, Shi, HL, Ji, G, et al. (2011) Effects of taraxerol and taraxerol acetate on cell cycle and apoptosis of human gastric epithelial cell line AGS. Journal of Chinese Integrative Medicine 9(6): 638–642.
Google Scholar | Crossref | Medline13. Yaoi, X, Lu, B, Lü, C, et al. (2017) Taraxerol induces cell apoptosis through a mitochondria-mediated pathway in HeLa cells. Cell journal 19(3): 512–519.
Google Scholar | Medline14. Hong, J-F, Song, Y-F, Liu, Z, et al. (2016) Anticancer activity of taraxerol acetate in human glioblastoma cells and a mouse xenograft model via induction of autophagy and apoptotic cell death, cell cycle arrest and inhibition of cell migration. Molecular Medicine Reports 13(6): 4541–4548.
Google Scholar | Crossref | Medline15. Li, R, Ma, X, Song, Y, et al. (2019) Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: analyses of network pharmacology, human and experimental data. Journal of Cellular Biochemistry 120: 11265–11273.
Google Scholar | Crossref16. Zhang, Q, Liu, J, Li, R, et al. (2020) A network pharmacology approach to investigate the anticancer mechanism and potential active ingredients of rheum palmatum L. Against lung cancer via induction of apoptosis. Frontiers in Pharmacology 11: 528308.
Google Scholar | Crossref | Medline17. Luo, Y, Feng, Y, Song, L, et al. (2019) A network pharmacology-based study on the anti-hepatoma effect of Radix Salviae Miltiorrhizae. Chinese Medicine 14: 27.
Google Scholar | Crossref | Medline18. Zhou, R, Wu, K, Su, M, et al. (2019) Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma. Environmental Toxicology and Pharmacology 70: 103200.
Google Scholar | Crossref | Medline19. Li, R, Song, Y, Ji, Z, et al. (2020) Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: network and experimental analyses. Biofactors 46(1): 158–167.
Google Scholar | Crossref | Medline20. Tari, AM, Lopez-Berestein, G (2001) GRB2: a pivotal protein in signal transduction. Seminars in Oncology 28(5 Suppl 16): 142–147.
Google Scholar | Crossref | Medline21. Andrade, VP, Morrogh, M, Qin, L-X, et al. (2015) Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion. Molecular Oncology 9(4): 772–782.
Google Scholar | Crossref | Medline22. Normanno, N, De Luca, A, Bianco, C, et al. (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366(1): 2–16.
Google Scholar | Crossref | Medline | ISI23. Huang, Y, Lin, J, Yi, W, et al. (2020) Research on the potential mechanism of gentiopicroside against gastric cancer based on network pharmacology. Drug Design, Development and Therapy 14: 5109–5118.
Google Scholar | Crossref | Medline24. Lu, S, Zhang, B, Wang, Z (2005) Expression of survivin, cyclinD1, p21(WAF1), caspase-3 in cervical cancer and its relation with prognosis. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 25(1): 78–81.
Google Scholar | Crossref | Medline25. Vermeulen, K, Van Bockstaele, DR, Berneman, ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Proliferation 36(3): 131–149.
Google Scholar | Crossref | Medline | ISI26. Cao, Z, Lin, W, Huang, Z, et al. (2013) Ethyl acetate extraction from a Chinese herbal formula, Jiedu Xiaozheng Yin, inhibits the proliferation of hepatocellular carcinoma cells via induction of G0/G1 phase arrest in vivo and in vitro. International Journal of Oncology 42(1): 202–210.
Google Scholar | Crossref | Medline27. Hartwell, LH, Kastan, MB (1994) Cell cycle control and cancer. Science 266(5192): 1821–1828.
Google Scholar | Crossref | Medline | ISI28. Harper, JW, Adami, GR, Wei, N, et al. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75(4): 805–816.
Google Scholar | Crossref | Medline29. Park, SY, Jeong, MS, Han, CW, et al. (2016) Structural and functional insight into proliferating cell nuclear antigen. Journal of Microbiology and Biotechnology 26(4): 637–647.
Google Scholar | Crossref | Medline30. Ioachim, E, Michael, M, Stavropoulos, NE, et al. (2004) Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Urologia Internationalis 73(1): 65–73.
Google Scholar | Crossref | Medline31. Fesik, SW (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nature Reviews Cancer 5(11): 876–885.
Google Scholar | Crossref | Medline32. Karmakar, S, Banik, NL, Ray, SK (2007) Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells. Neurochemical Research 32(12): 2103–2113.
Google Scholar | Crossref | Medline33. Ni, T, Wang, H, Li, D, et al. (2019) Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway. Biomedicine & Pharmacotherapy 118: 109241.
Google Scholar | Crossref | Medline34. Lou, Z, Wei, QQ, Wang, DW, et al. (2018) Effect of allicin on proliferation and apoptosis of KG-1 cells and its molecular mechanism. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 43(12): 2612–2617.
Google Scholar | Medline35. Pan, G, O’Rourke, K, Dixit, VM (1998) Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. Journal of Biological Chemistry 273(10): 5841–5845.
Google Scholar | Crossref | Medline | ISI36. Martínez-García, D, Manero-Rupérez, N, Quesada, R, et al. (2019) Therapeutic strategies involving survivin inhibition in cancer. Med Res Rev 39(3): 887–909.
Google Scholar | Crossref | Medline37. Shin, S, Sung, B-J, Cho, Y-S, et al. (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40(4): 1117–1123.
Google Scholar | Crossref | Medline38. Liang, JH, Luo, HL, Long, F, et al. (2016) Expression and significance of Survivin and Bcl-2 in nasal aquamous cell carcinoma. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery 30(7): 529–531.
Google Scholar | Medline39. Bao, L, Liu, F, Guo, H-b, et al. (2016) Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway. Tumor Biology 37(8): 11365–11374.
Google Scholar | Crossref | Medline40. Lim, SC (2001) Expression of matrix metalloproteinases and its inhibitor in gastric adenocarcinoma. Cancer Research and Treatment 33(3): 199–206.
Google Scholar | Crossref | Medline41. Lyu, Z-K, Li, C-L, Jin, Y, et al. (2017) Paeonol exerts potential activities to inhibit the growth, migration and invasion of human gastric cancer BGC823 cells via downregulating MMP-2 and MMP-9. Molecular Medicine Reports 16(5): 7513–7519.
Google Scholar | Crossref | Medline42. Hennessy, BT, Smith, DL, Ram, PT, et al. (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews Drug Discovery 4(12): 988–1004.
Google Scholar | Crossref | Medline | ISI43. Yang, J-h, Yu, K, Si, X-k, et al. (2019) Liensinine inhibited gastric cancer cell growth through ROS generation and the PI3K/AKT pathway. Journal of Cancer 10(25): 6431–6438.
Google Scholar | Crossref | Medline